Search Results

Search Results for "transvaginal mesh"

• Troubled Johnson & Johnson issues another recall
  A unit of Johnson & Johnson has issued a recall for certain lots of bone putty, which is used to stop bone bleeding by creating a physical barrier along the edges of bones damaged by trauma or cut during a surgical procedure. Reuters reports that Synthes issued the recall on July 5, citing the p...

• Defibrillator concerns spotlight problems with medical devices
  A cardiologist who conducted a study of St. Jude Medical defibrillator leads said surgeons should stop implanting them in patients until more research is done about safety concerns surrounding the devices. The New York Times quotes Dr. Robert G. Hauser of Abbott Northwestern Hospital in Minneapolis ...

• J&J pledges to remove harmful chemicals from products
  According to the New York Times, Johnson & Johnson has pledged to remove a number of potentially harmful chemicals, including formaldehyde, from its line of consumer products by the end of 2015. Although the company had already pledged to remove certain chemicals from its baby products by 2013, ...

• Studies ordered on recipients of dangerous medical device
  The U.S. Food and Drug administration has ordered St. Jude Medical to do additional studies on patients implanted with medical device components that are blamed in as many as 20 deaths. According to the New York Times, the FDA has also recommended that patients who received the Riata defibrillator l...

• Specialists available to treat urinary incontinence
  According to the Mayo Clinic, many health care providers can treat bladder control problems without referring you to a specialist. But not all primary care providers have the necessary training or experience. And despite the current improved understanding and treatment of urinary incontinence, some ...

• Individual charges rare in corporate fraud cases
  According to a story in the New York Times, a renewed U.S. Justice Department emphasis on prosecuting corporate fraud is expected to bring in as much as $8 billion this year from pharmaceutical companies, military contractors, banks and other corporations charged with defrauding the government, whic...

• Analyst says Johnson & Johnson should break up
  A prominent Wall Street analyst is suggesting that the best way for Johnson & Johnson to cope with its many problems would be to break into smaller companies, according to an article in the Asbury Park Press. Jami Rubin of Goldman Sachs suggests that splitting Johnson & Johnson’s three div...

• Johnson & Johnson unit sued over Norian SRS death
  Johnson & Johnson’s Synthes unit, a maker of tools and implants to treat damaged bones, has been sued by the family of a woman who died during an unapproved trial of a bone cement, Bloomberg reports. It’s an ironic development for Johnson & Johnson, which recently purchased Synthes for $...

• Pa. appeals court sides with J&J
  A state appeals court has upheld the dismissal of Pennsylvania’s lawsuit against Johnson & Johnson over allegations that the company improperly marketed its antipsychotic drug Risperdal, the Wall Street Journal reports. Pennsylvania prosecutors had filed suit against J&J in 2007, trying to...

• Johnson & Johnson reaches deal with prosecutors
  The Wall Street Journal reports that Johnson & Johnson and federal prosecutors have reached a settlement over allegations that the company illegally marketed its antipsychotic drug Risperdal and other medications. That settlement will reportedly be about $2.2 billion, and include about $400 mill...